Moody's Investors Service has affirmed Seattle-based Virginia Mason Medical Center's "Baa2" long-term and underlying revenue bond ratings, affecting $451 million of debt.
The rating affirmation is based on a number of factors, including VMMC's unique and stable value proposition.
Challenges to the organization include a relatively high amount of debt and a history of variable and somewhat suppressed margins.
The rating outlook is stable, reflecting Moody's view that despite challenges to operations in the short term, management is expected to be able to assist the organization and return margins to current levels.